Multiple organ failure and outcome of critically ill patients with haematological malignancy

Acta Anaesthesiologica Scandinavica

Volumn 47, Issue 3, 2003, Pages 301-306

  Silfvast, Tom ^a,c   Pettila V ^a   Ihalainen, A ^a   Elonen, E ^b  

^a Meilahti Hospital   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NONE   (Finland)

Author keywords

Hematologic neoplasms; Intensive care; Mortality; Multiple organ failure; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CRITICAL ILLNESS; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INTENSIVE CARE UNIT; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPENIA; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; APACHE; CRITICAL ILLNESS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037355107     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2003.00058.x     Document Type: Article

References (26)

1. Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ. Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med 1986; 12: 317-24.
2. Yau E, Rohatiner AZS, Lister TA, Hinds CJ. Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. Br J Cancer 1991; 64: 938-42.
3. Epner DE, White P, Krasnoff M, Khanduja S, Kimball KT, Knaus WA. Outcome of mechanical ventilation for adults with hematologic malignancy. J Invest Med 1996; 44: 254-60.
4. Ashkenazi YJ, Kraemer BS, Harman E. Short-term outcome among patients with leukaemia and lymphoma admitted to a medical intensive care unit. South Med J 1986; 79: 1086-8.
5. Brunet F, Lanore JJ, Dhainaut JF et al. Is intensive care jurstified for patients with haematological malignancies? Intensive Care Med 1989; 16: 291-7.
6. Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB. Outcomes of critically ill cancer patients in a University hospital setting. Am J Respir Crit Care Med 1999; 160: 1957-61.
7. Blot F, Guiguet M, Nitenberg G, Leclerq B, Gachot B, Escudier B. Prognostic factors for neutropenic patients in an intensive care unit: Respective roles of underlying malignancies and acute organ failures. Eur J Cancer 1997; 33: 1031-7.
8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
9. Vincent JL, Moreno R, Takala J et al. on behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707-10.
10. Ruttimann UE. Statistical approaches to development and validation of predictive instruments. Crit Care Clin 1994; 10: 19-36.
11. Diaconis P, Efron P. Computer-intensive methods in statistics. Sci Am 1983; 248: 116.
12. Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ. Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy. BMJ 1988; 296: 1025-9.
13. Evison JM, Rickenbacher P, Gratwohl A, Haberthur C, Elsasser S, Passsweg JR. Intensive care unit admission in patients with haematological disease. Incidence, outcome and prognostic factors. Swiss Med Wkly 2001; 131: 681-6.
14. Khassawneh BY, White P, Anaissie EJ, Barlogie B, Hiller C. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 2002; 121: 185-8.
15. Vincent JL, deMendonca A, Cantraine F et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26: 1793-800.
16. Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent J-L. Time course of platelet counts in critically ill patients. Crit Care Med 2002; 30: 753-6.
17. Guiguet M, Blot F, Escudier B, Antoun S, Leclerc B, Nitenberg G. Severity-of-illness scores for neutropenic cancer patients in an intensive care unit: Which is the best predictor? Crit Care Med 1998; 26: 488-93.
18. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286: 1754-8.
19. Johnson MH, Gordon PW, Fitzgerald FT. Stratification of prognosis in granulocytopenic patients with haematological malignancies using the APACHE-II severity of illness score. Crit Care Med 1986; 14: 693-7.
20. Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998; 158: 876-84.
21. Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M et al. Outcome and prognostic features of intensive care unit treatment in patients with haematological malignancies. Intensive Care Med 2002; 28: 1289-1300.
22. Staudinger T, Stoiser B, Mullner M et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28: 1322-8.
23. Azoulay E, Recher C, Alberti C et al. Changing use of intensive care for hematological patients. Intensive Care Med 1999; 25: 1395-401.
24. Peters SG, Meadows JA, Gracey DR. Outcome of respiratory failure in hematologic malignancy. Chest 1988; 94: 99-102.
25. Denardo SJ, Oye RK, Bellamy PE. Efficacy of intensive care for bone marrow transplant patients with respiratory failure. Crit Care Med 1989; 17: 4-6.
26. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 1992; 67: 117-22.